Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Anti-tumor effect of recombinant plasminogen kringle 1-3 in KB cells: Histological observation and immunoprecipitation-based high performance liquid chromatography

Oral Biology Research 2017³â 41±Ç 2È£ p.45 ~ 54
ÀÌ»ó¿î, ¹Ú¿µ¿í, À̼®±Ù, ÀÌÈñ¼ö,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌ»ó¿î ( Lee Sang-Woon ) - University of Ulsan College of Medicine Gangneung Asan Hospital Department of Dentistry
¹Ú¿µ¿í ( Park Young-Wook ) - Gangneung-Wonju National University College of Dentistry Department of Oral and Maxillofacial Surgery
À̼®±Ù ( Lee Suk-Keun ) - Gangneung-Wonju National University College of Dentistry Department of Oral Pathology
ÀÌÈñ¼ö ( Lee Hee-Su ) - Gangneung-Wonju National University College of Dentistry Department of Oral Anatomy

Abstract


Angiostatin containing plasminogen kringle 1-4 domain is an endogenous angiogenesis inhibitor with anti-tumor effect. The present study applied recombinant human plasminogen kringle 1-3 (rPK1-3) in KB cell culture and BALB/c-nude mice, to elucidate the in vitro and in vivo anti-tumorigenic effect. Nude mice (n = 4) treated with rPK1-3, were compared to cisplatin treated nude mice (n = 4) and saline controls (n = 2). In vitro, the KB cells were also exposed to 10 ¥ìM of rPK1-3 for 12 and 24 hours. Cells were evaluated histologically, and their protein expression was analyzed by immunoprecipitation-based high performance liquid chromatography (IP-HPLC). Results revealed that rPK1-3 potently inhibited the growth of KB cells in cell culture, but not in animal study. The KB cells treated with rPK1- 3 showed growth arrest with decreased expression of PCNA, Ki-67, and MPM2, but enhanced apoptosis and increased expression of p53, BID, BAK, BAX, and caspase 9. Reduced cellular adaptation was also observed, with decreased expression of TGF-¥â1, SMAD4, pAKT, mTOR, EGFR, and PKC. Anti-angiogenesis effects with decreased expression of VEGF-A, VEGFR, angiogenin, vWF, LYVE-1, D2-40, CD31, MMP-2, and bFGF were also observed in cells treated with rPK1-3. These results suggest that in vitro, rPK1-3 has potent anti-tumorigenic effects, such as growth inhibition, increased apoptosis, reduced cellular survival, and tumor anti-angiogenesis. Therefore, rPK1-3 can be used as an anti-tumor agent for tumor cells in the absence of host systemic responses, including antibody formation.

Å°¿öµå

Angiostatins; Immunoprecipitation-based high performance liquid chromatography (IP-HPLC); KB cells; Plasminogen

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI